BioNTech SE (BNTX) EBT Margin Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -5,037.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -915,233.00 |
| Sep 30, 2025 | -1,112.00 |
| Jun 30, 2025 | 230,230.00 |
| Mar 31, 2025 | 168,669.00 |
| Dec 31, 2024 | 908,243.00 |
| Sep 30, 2024 | -1,265.00 |
| Jun 30, 2024 | -221,091.00 |
| Mar 31, 2024 | -366,194.00 |
| Dec 31, 2023 | -2,931.00 |
| Sep 30, 2023 | -4,521.00 |
| Jun 30, 2023 | -31,835.00 |
| Mar 31, 2023 | -2,330.00 |
| Dec 31, 2022 | -1,105.00 |
| Sep 30, 2022 | -606.00 |
| Jun 30, 2022 | -322.00 |
| Mar 31, 2022 | -145.00 |
| Sep 30, 2021 | -23,073.00 |
| Jun 30, 2021 | -14,092.00 |
| Mar 31, 2021 | -11,261.00 |
| Sep 30, 2020 | 20,241.00 |
| Jun 30, 2020 | 2,252.00 |
| Mar 31, 2020 | 3,695.00 |
| Sep 30, 2019 | -730.00 |